1. An open-label, single-arm, phase 1 study to assess biomarker effects, efficacy and safety of ofatumumab in patients with refractory chronic lymphocytic leukemia. Issue 10 (3rd October 2015) Authors: Patton, William Nigel; Lindeman, Robert; Butler, Andrew C.; Kipps, Thomas J.; Jewell, Roxanne C.; Laubscher, Kevin H.; Zhou, Yan Yan; Lewis, Eric; Sedoti, Donna; Witman, Philip; Fang, Lei; Chan, Geoffrey Journal: Leukemia & lymphoma Issue: Volume 56:Issue 10(2015:Oct.) Page Start: 2819 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Anti-retinal IgG antibodies in patients with early and advanced type 2 macular telangiectasia. (May 2022) Authors: McLenachan, Samuel; Balaratnasingam, Chandrakumar; Heath Jeffery, Rachael C.; Chen, Shang-Chih; Zhang, Dan; Chan, Geoffrey; Dolz-Marco, Rosa; Bacci, Tommaso; Lo, Johnny; Wiffen, Steven; Yannuzzi, Lawrence A.; Chen, Fred K. Journal: Experimental eye research Issue: Volume 218(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Assessment of the effect of ofatumumab on cardiac repolarization. (21st August 2014) Authors: Jewell, Roxanne C.; Laubscher, Kevin; Lewis, Eric; Fang, Lei; Gafoor, Zarina; Carey, Jodi; McKeown, Astrid; West, Sarah; Wright, Oliver; Sedoti, Donna; Dixon, Iestyn; Hottenstein, Charles Scott; Chan, Geoffrey Journal: Journal of clinical pharmacology Issue: Volume 55:Number 1(2015:Jan.) Page Start: 114 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Corrigendum to "Phase 1/2 trial of glasdegib in patients with primary or secondary myelofibrosis previously treated with ruxolitinib" [Leukemia Res. 79 (2019) 38–44]. (June 2019) Authors: Gerds, Aaron T.; Tauchi, Tetsuzo; Ritchie, Ellen; Deininger, Michael; Jamieson, Catriona; Mesa, Ruben; Heaney, Mark; Komatsu, Norio; Minami, Hironobu; Su, Yun; Shaik, Naveed; Zhang, Xiaoxi; DiRienzo, Christine; Zeremski, Mirjana; Chan, Geoffrey; Talpaz, Moshe Journal: Leukemia research Issue: Volume 81(2019) Page Start: 105 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Evaluation of the Relationship of Glasdegib Exposure and Safety End Points in Patients With Refractory Solid Tumors and Hematologic Malignancies. (24th September 2020) Authors: Ruiz‐Garcia, Ana; Shaik, Naveed; Lin, Swan; Jamieson, Catriona; Heuser, Michael; Chan, Geoffrey Journal: Journal of clinical pharmacology Issue: Volume 61:Number 3(2021) Page Start: 349 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Glasdegib in combination with cytarabine and daunorubicin in patients with AML or high‐risk MDS: Phase 2 study results. Issue 11 (9th September 2018) Authors: Cortes, Jorge E.; Douglas Smith, B.; Wang, Eunice S.; Merchant, Akil; Oehler, Vivian G.; Arellano, Martha; DeAngelo, Daniel J.; Pollyea, Daniel A.; Sekeres, Mikkael A.; Robak, Tadeusz; Ma, Weidong Wendy; Zeremski, Mirjana; Naveed Shaik, M.; Douglas Laird, A.; O'Connell, Ashleigh; Chan, Geoffrey; ... Journal: American journal of hematology Issue: Volume 93:Issue 11(2018:Nov.) Page Start: 1301 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Malaria Screening Using Front-Line Loop-Mediated Isothermal Amplification: Fourteen-Month Experience in a Nonendemic Regional Hub-and-Spoke Laboratory Setting. Issue 5 (7th December 2020) Authors: McGinnis, Eric; Chan, Geoffrey; Hudoba, Monika; Markin, Todd; Yakimec, Jim; Roland, Kristine Journal: American journal of clinical pathology Issue: Volume 155:Issue 5(2021) Page Start: 690 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Phase 1/2 trial of glasdegib in patients with primary or secondary myelofibrosis previously treated with ruxolitinib. (April 2019) Authors: Gerds, Aaron T.; Tauchi, Tetsuzo; Ritchie, Ellen; Deininger, Michael; Jamieson, Catriona; Mesa, Ruben; Heaney, Mark; Komatsu, Norio; Minami, Hironobu; Su, Yun; Shaik, Naveed; Zhang, Xiaoxi; DiRienzo, Christine; Zeremski, Mirjana; Chan, Geoffrey; Talpaz, Moshe Journal: Leukemia research Issue: Volume 79(2019) Page Start: 38 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Phase I study of glasdegib (PF‐04449913), an oral smoothened inhibitor, in Japanese patients with select hematologic malignancies. Issue 8 (19th June 2017) Authors: Minami, Yosuke; Minami, Hironobu; Miyamoto, Toshihiro; Yoshimoto, Goichi; Kobayashi, Yukio; Munakata, Wataru; Onishi, Yasushi; Kobayashi, Masahiro; Ikuta, Mari; Chan, Geoffrey; Woolfson, Adrian; Ono, Chiho; Shaik, Mohammed Naveed; Fujii, Yosuke; Zheng, Xianxian; Naoe, Tomoki Journal: Cancer science Issue: Volume 108:Issue 8(2017) Page Start: 1628 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Quantitative analysis of astrocyte and axonal density relationships: Glia to neuron ratio in the optic nerve laminar regions. (September 2020) Authors: Chan, Geoffrey; Morgan, William H.; Yu, Dao-Yi; Balaratnasingam, Chandrakumar Journal: Experimental eye research Issue: Volume 198(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗